Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 17)
3 February 2026
Novo Nordisk Reports 6% Sales Growth in DKK, 10% at CER for 2025
Operating profit fell 1% in DKK, rose 6% at CER. US FDA approved oral GLP-1 for obesity. 2026 sales growth expected to decline due to pricing and competition. New treatments in pipeline.
3 February 2026
Novo Nordisk 2025 Financial Report
Sales rose 10% at CER, operating profit up 6%. US FDA approved oral GLP-1. 2026 outlook: sales/profit growth -5% to -13% at CER. New share repurchase program announced.
3 February 2026
DOMO Polymer Solutions Spain Enters Insolvency
The company is assessing solutions under court supervision. Operations in Blanes are paused, affecting 100 employees. Restructuring options are being reviewed.
3 February 2026
Merck Announces Q4 and Full-Year 2025 Financial Results, Highlights Pipeline Progress
Strong oncology and animal health sales, positive trial results, and strategic acquisitions drive growth. 2026 outlook projects sales up to $67B, with EPS impacted by acquisition charges.
3 February 2026
Aramco Completes $4 Billion Bond Issuance
Aramco issued $4B in bonds across four tranches, with attractive pricing and negative new issue premiums, reflecting strong credit quality and financial discipline.
3 February 2026
Ørsted Divests European Onshore Business to CIP
The transaction, valued at EUR 1.44 billion, is set to close in Q2 2026, refocusing efforts on offshore wind and strengthening financials.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
3 February 2026
AkzoNobel Reports Q4 and FY 2025 Profit Margin Growth
Organic sales dipped, but efficiency boosted margins. Operating income rose, cash flow improved, and a merger with Axalta is proposed. No major market recovery expected in 2026.
3 February 2026
Boliden Q4 2025 Report: Strong Metal Prices Boost Performance
Stable production, record mine profits, and strong metal prices marked Q4. Operating profit reached SEK 4,061m, with a proposed dividend of SEK 11.00 per share.
2 February 2026
Equinor Sells Argentina Onshore Assets to Vista Energy
Equinor divests its Vaca Muerta onshore assets for $1.1B, enhancing financial flexibility and focusing on offshore opportunities.
30 January 2026
WACKER Increases Silicone Prices
Prices for silicone products rise due to increased platinum costs, affecting sectors like automotive and medical. Existing contracts will be amended.
30 January 2026
thyssenkrupp: From Decisions to Implementation in Transformation Journey
AGM approves agenda; TKMS listed on MDAX; share value up 135%; ACES 2030 model launched; €0.15 dividend; Supervisory Board re-elected; focus on sustainable success.
30 January 2026
Chevron Q4 2025 Financial Results
Earnings at $2.8B, adjusted $3.0B. Cash flow $10.8B, free cash $4.2B. Production up 12% globally, 16% U.S. Reserve replacement 158%. Dividend up 4% to $1.78/share.
30 January 2026
LyondellBasell 2025 Earnings Report
Net loss of $738M; $563M excluding items. EBITDA at $1.1B; $2.5B excluding items. Cash from operations $2.3B. Exceeded cash plan by $200M. European asset divestment on track for 2026.
29 January 2026
Dow Q4 2025 Financial Results
Net sales fell 9% YoY. GAAP net loss was $1.5B. Op. EBIT dropped $421M. Cost savings partly offset declines. Dividends totaled $251M. CEO highlights cost actions and future productivity goals.
29 January 2026
Iberdrola Sells Spanish Gas Plants to Edison Next
The sale includes five gas plants and four biomethane projects, aligning with a strategy to focus on electrification and renewable energy.
29 January 2026
Dow unveils Transform to Outperform for enhanced productivity and growth
Dow aims for $2B Op. EBITDA boost by simplifying operations, cutting costs, and modernizing customer service, with $1.1-1.5B in one-time costs, including severance for 4,500 roles.
29 January 2026
Eastman Reports Q4 and 2025 Financial Results
Generated nearly $1B cash, exceeded cost savings goals, increased production, and raised dividends for the 16th year, returning $500M to stockholders.
29 January 2026
Takeda Q3 FY2025 Results: VYVANSE® Generics Impact, Cost Management, and Upcoming Launches
Revenue and core profit declined, but operating profit rose. New drug applications submitted, with launches expected in 18 months, aiming for long-term growth.
29 January 2026
Roche Reports 7% Sales Growth in 2025 Results
Pharmaceuticals and diagnostics drive profit and earnings growth. Key approvals and advancements in therapies. Dividend increase proposed. Board changes announced. Positive 2026 outlook.
28 January 2026
Wacker Chemie AG Meets 2025 Expectations Despite Market Challenges
Sales and EBITDA fell due to weak demand, lower volumes, and currency effects. PACE project aims to cut costs. Net cash flow improved by reducing inventories.
26 January 2026
trinamiX Management Change at BASF
BASF explores strategic options for trinamiX, focusing on restructuring and cost efficiency. Dr. Lothar Laupichler replaces Dr. Ingmar Bruder as Managing Director.
26 January 2026
LANXESS Increases Adipic Acid Prices
Prices rise by EUR 100/ton due to higher raw material costs. Adjustment ensures supply reliability and sustainability.
22 January 2026
LanzaTech Closes $20M Private Placement
LanzaTech secures $20M from investors to advance carbon recycling projects in Asia and Europe, enhancing energy resilience and sustainable fuel production.
22 January 2026
Iberdrola Sells Hungarian Wind Assets for €171 Million
Iberdrola sold 158 MW of wind capacity in Hungary, aligning with its strategy to focus on core businesses and key markets like the US and UK.
22 January 2026
Eni Sells 10% Stake in Baleine Project to SOCAR
The sale aligns with Eni's strategy to optimize its portfolio and follows prior MoUs with SOCAR. Baleine, a net-zero project, boosts Cote d'Ivoire's energy output. Regulatory approval pending.
21 January 2026
Genmab Reports 2025 DARZALEX Sales
2025 DARZALEX sales reached USD 14,351 million, with USD 8,266 million in the U.S. and USD 6,085 million elsewhere. Genmab earns royalties from J&J's global sales.
20 January 2026
ADNOC Enters Global Top 100 Brands
ADNOC's brand value rose 11% to $21.13B in 2026, maintaining its top UAE brand status for eight years and ranking sixth globally in oil-and-gas, driven by AI, growth, and decarbonization.
14 January 2026
Sinopec Capital Invests in Faurecia Hydrogen Energy
Sinopec Capital's investment marks its first project in China's hydrogen energy sector, aiming to enhance the hydrogen industry chain and foster a collaborative ecosystem.
14 January 2026
TotalEnergies to Divest 10% Stake in Nigerian JV
TotalEnergies sells its 10% interest in Renaissance JV's oil and gas licenses in Nigeria to Vaaris, retaining economic interest in key gas licenses. Closing awaits regulatory approval.
14 January 2026
Essar Energy Transition Achieves Record Sales in 2025
In 2025, domestic sales hit record highs, driven by retail and aviation growth, infrastructure upgrades, and a focus on decarbonization.
← Previous
Next →
